Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration

Korean Journal of Internal Medicine

Volumn 26, Issue 1, 2011, Pages 68-75

  Park, Joon Sung ^a   Kim, Gheun Ho ^a   Kang, Chong Myung ^a   Lee, Chang Hwa ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Anticoagulation; Citric acid; Heparin; Renal replacement therapy

Indexed keywords

ACID CITRATE DEXTROSE; GLUCONATE CALCIUM; HEPARIN;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; APACHE; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; HYPOTENSION; LIFESPAN; LIVER TOXICITY; LUNG HEMORRHAGE; MALE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT WITHDRAWAL;

ADULT; AGED; ANTICOAGULANTS; CITRIC ACID; CRITICAL ILLNESS; FEMALE; HEALTH CARE COSTS; HEMODIAFILTRATION; HEPARIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED;

EID: 79953280355     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2011.26.1.68     Document Type: Article

References (14)

1. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-1997.
2. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodi- afiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006;1:79-87.
3. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-2367.
4. Cointault O, Kamar N, Bories P, et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004;19:171-178.
5. Munjal S, Ejaz AA. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations. Nephrology (Carlton) 2006;11:405-409.
6. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-265.
7. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
8. Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000;26:1652-1657.
9. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575-578.
10. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005;20:155-161.
11. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33:1563-1570.
12. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-374.
13. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981.
14. Brophy PD, Somers MJ, Baum MA, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 2005;20:1416-1421.